HomeChemicals and MaterialsSpecialty ChemicalsCanada Barium Sulphate Market

Canada Barium Sulphate Market For Contrast Media Size, Share, Opportunities And Trends By Method Of Administration (Oral, Rectal, IV), By Procedure (X-Ray, Computer Tomography, Fluoroscopy), By End-User (Hospitals, Diagnostic Centers), And By Province - Forecasts From 2022 To 2027

📥 Download Free Sample💬 Speak to Analyst
$3,350
Single User License
Access Full Insights
Report OverviewSegmentationTable of ContentsCustomize Report

Table of Contents

1. INTRODUCTION

1.1. Market Overview

1.2. Covid-19 Scenario

1.3. Market Definition

1.4. Market Segmentation

 

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

 

3. EXECUTIVE SUMMARY

3.1. Research Highlights

 

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

 

5. CANADA BARIUM SULPHATE MARKET FOR CONTRAST MEDIA, BY METHOD OF ADMINISTRATION

5.1. Introduction

5.2. Oral

5.3. Rectal

5.4. IV

 

6. CANADA BARIUM SULPHATE MARKET FOR CONTRAST MEDIA, BY PROCEDURE

6.1. Introduction

6.2. X-Ray

6.2.1. By Method of Administration

6.3. Computer Tomography

6.3.1. By Method of Administration

6.4. Fluoroscopy

6.4.1. By Method of Administration

 

7. CANADA BARIUM SULPHATE MARKET FOR CONTRAST MEDIA, BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Diagnostic Centers

 

8. CANADA BARIUM SULPHATE MARKET FOR CONTRAST MEDIA, BY PROVINCE

8.1. Introduction

8.2. Alberta

8.3. British Columbia

8.4. Ontario

8.5. Others

 

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

 

10. COMPANY PROFILES

10.1. Bracco S.p.A.

10.2. Guerbet

10.3. Voyageur Pharma

10.4. Merck & Co., Inc.

REPORT DETAILS

Report ID:KSI061614227
Published:Jan 2023
Pages:120
Format:PDF, Excel, PPT, Dashboard
📥 Download Sample📞 Speak to Analyst📧 Request Customization

Need Assistance?

Our research team is available to answer your questions.

Contact Us